Objective: To compare the prophylactic efficacy o f 1 g ceftriaxone with 1,5 g cefuroxime + 0.5 g metronidazole for febrile morbid ity and urinary tract infection in patients undergoing vaginal hysterectomy. Study design: A prospective, randomized, comparative, non-blinded study with at least 100 patients on each side. The two-sample /-test was used for testing equality o f two means and the x 2 test was used for pair differences. Results: Single dose cefuroxime + metronidazole and ceftriaxone were equally effective in preventing febrile morbidity postoperatively. Additionally ceftriaxone was more effective in sterilizing pre-operatively existing bacteriuria. spectrum includes most gram-negative rods, grampositive cocci, except enterococci, and Bacteroides spe cies. Single dose ceftriaxone has proved to be as ef ficacious as three doses o f cefazolin [7], To our knowledge it has not previously been compared with a single dose of cefuroxime + metronidazole.
Introduction

Patients undergoing vaginal hysterectomy with or without repair need antibiotic prophylaxis to prevent febrile morbidity and vaginal top infections. The effi cacy o f single dose o f some antibiotics has been proved comparable with multiple dose regimens over 12-24 h [1-4], Many antibiotics have been used but there is no general agreement about the most suitable antibiotic.
Wound infections after hysterectomy are often polymicrobial and it is commonly accepted that prophy laxis should be directed against aerobic and anaerobic bacteria. Cefuroxime in combination with metronida zole is often used in this field and there is some experi ence with a single dose regimen [5, 6] . We compared the prophylactic efficacy of this regimen with that o f cef triaxone.
Ceftriaxone is a broad spectrum cephalosporin with a prolonged half-life in serum of approximately 8 h and its 144 W.K. Brouwer, J.A.A. Hoogkamp Korstanje / European Journal of Obstetrics & Gynecology and Reproductive Biology 61 (1995) [143] [144] [145] [146] after informed consent was obtained. Inclusion criteria for entry were: patients referred to our practice for vagi nal hysterectomy with or without a prolapse repair, if they had no antibiotics during the preceeding 2 days and if they had normal liver and kidney functions.
Patients were alternately allocated to one of the two regimens o f prophylaxis. The study was stopped when at least 100 patients in each group were evaluable. The study period was from 1 March 1989 until 1 July 1993.
All patients were operated by three gynaecologists or by registrars under direct supervision, all using the same technique. Patients who underwent a vaginal hysterecto my without repair were given an indwelling urethral catheter which was routinely removed after 1 or 2 days. Patients who also underwent a repair normally were given a suprapubic urinary catheter at the end of the op eration which was removed after 7 days. Operation in dication, details and duration were recorded for each patient.
Rectal temperature readings were recorded twice daily postoperatively and patients were observed daily for signs o f infection. Diagnosis and criteria for post operative infections were: (1) febrile morbidity (> 38 °C rectal temperature over 2 days, excluding the first 48 h);
(
2) cuff infection (clinically obvious signs of vaginal top or cuff infection with palpable abnormality, fever and purulent discharge); (3) urinary tract infection (UTI):
* bacteriuria (>10 000 microorganisms/ml urine).
Antimicrobial prophylaxis
Patients received one dose o f 1.5 g cefuroxime + 0.5 g metronidazole or 1 g ceftriaxone in 100 ml isotonic salt solution via 10 min i.v. infusion at the start of anaes thesia.
Bacteriology
Urine catheter samples were cultured qualitatively and quantitatively before operation, at catheter removal and on indication. A direct preparation was made and the urine was diluted and plated on blood agar and McConkey agar. After 24 h at 37 °C, the colonies were counted and the original number of organisms per ml was estimated. All significant organisms were identified and their susceptibilities to various antibiotics were determined.
Other materials were cultured according to routine methods for aerobic and anaerobic bacteria.
Statistical analysis
The Student's i-test was used for testing equality o f two means and the x 2-test was used for pair differences (P < 0.05 was taken as indicating statistical signif icance).
Results
Two-hundred fifty-six women entered the study; 30 patients were excluded from the evaluation because they did not receive the antibiotic according the protocol, or their preoperative or postoperative urine culture was not known, or they were not operated according to the pro- Table 2 Table  3 ). The mean hospital stay was similar for those without pre-existing bacteriuria (about 8.5 days) and those on ceftriaxone with pre-existing bacteriuria, but was significantly longer for those with pre-existing bacter iuria on cefuroxime (11.6 days) (P < 0.02). Escherichia coli was the main pathogen in both treatments groups; 
shows the two treat ment groups according to catheterisation procedures: patients with a suprapubic catheter and no pre-existing urinary tract infection receiving ceftriaxone had less urinary tract infection (8 o f 65) than patients receiving cefuroxime + metronidazole (14 o f 59), although the difference is not significant. In patients with a pre existing bacteriuria and a suprapubic catheter also, in the ceftriaxone regimen there were less urinary tract in fection (two o f eight) than in the cefuroxime + metro nidazole regimen (14 of 15) (P < 0.001). Enterococci and Escherichia coli were predominant pathogens in urine of patients treated with cefuroxime + metronidazole, enterococci were also the main patho gens o f urine o f patients treated with ceftriaxone (
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Streptococcus agalactiae Biology 61 (1995) 143-146 it persisted under cefuroxime treatment, but was eliminated under ceftriaxone ( Table 3) . Proteus mirabilis and Enterococcus faecalis persisted as well under cefuroxime treatment. All patients with postoperative urine tract infection were treated with appropriate drugs and cured.
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Discussion
Infectious morbidity following vaginal hysterectomy has been significantly reduced by use o f perioperative prophylactic antibiotics, Most antibiotic regimens have included one pre-operative dose following by two or three postoperative doses [3, 4] , The preoperative dose is the critical one and it might not be necessary to continue antibiotic treatment postoperatively [8] . A limited num ber of postoperative trials have studied single dose regimens. Mostly one dose was compared with three or four doses of the same or another comparable drug, often cefazolin [3] , Ceftriaxone has been compared with multidose cefazolin and no difference in efficacy or se lection of resistant isolates was found [3, 7] . The authors found that the total costs for ceftriaxone were greater than for cefazolin and this led in 1991 to the recommen dation that cefazolin should remain the drug o f choice for prophylaxis o f infection in uncomplicated vaginal hysterectomy [3] . Stiver et al. [7] found 8% febrile mor bidity in 65 patients for ceftriaxone. In our study we found 5% febrile morbidity in 112 patients on ceftriax one. This figure is comparable with our findings for sin gle dose cefuroxime + metronidazole. In her thesis, Wttewaall-Evelaar [9] stated that perioperative prophy laxis do not prevent postoperative bacteriuria. In our study ceftriaxone seems to reduce the frequency o f post operative urinary tract infections. Thirty-one women treated with cefuroxime (27%) vs, 13 treated with with ceftriaxone (12%) had to be treated for postoperative urine tract infection. A total o f 25 women appeared to have a urinary tract infection before operation. They were all of older age and were operated for hysterectomy with repair. In fact, they had to be treated before, but the results of culture taken at admittance are mostly not available in time. Single dose ceftriaxone was sufficient to sterilize the urine in nine patients (eight infected with Enterobacteriaceae) althought it selected in three of them for enterococci, but there was no need for extra treatment and prolonged stay. On the contrary, single dose cefuroxime was insufficient to treat pre-existing urine tract infections by E. coli and P. mirabilis. Patients with these infections required extra treatment and had prolonged hospital stay by 3.3 days. Costs of extra treat ment and additional prolongation of hospital stay total ly offset the cost savings o f the cheaper regimen, cefuroxime + metronidazole.
The prolonged half life and subsequent prolonged ex posure to adequate drug concentration by ceftriaxone may explain the beneficial effect on preventing postop erative urine tract infection. This additional effect is an advantage over cefuroxime having a short half life. We had the same experience in a comparable trial with one dose ciprofloxacin, having also a long half life, where we found only 7% o f women developing post-operative urinary tract infection [4] , A three-dose regimen o f cefuroxime + metronidazole, also providing prolonged antibiotic coverage at adequate concentrations, revealed only 13% urinary tract infection postoperatively [4] .
To prevent postoperative urinary tract infections by peri-operative (single dose) prophylaxis, drugs with a prolonged half life are preferred.
